Production and response of a human prostatic cancer line to transforming growth factor-like molecules
- PMID: 2223575
- PMCID: PMC1971489
- DOI: 10.1038/bjc.1990.333
Production and response of a human prostatic cancer line to transforming growth factor-like molecules
Abstract
Serum-free media conditioned by the androgen insensitive human prostate cancer cell line DU145 showed immunological transforming growth factor-alpha (TGF alpha) activity, as well as competing activity in epidermal growth factor (EGF) radioreceptor assays (RRA). Furthermore, there were factors in the conditioned media which inhibited and stimulated DNA synthesis by DU145 cells in a dose-dependent fashion. Fractionation of the concentrated conditioned media by reverse-phase high performance liquid chromatography revealed several peaks containing EGF-like competitive activity only one of which demonstrated TGF alpha activity. However, none of the peaks corresponded to immunoreactive EGF. Measurement of EGF receptors on DU145 cells by competition and saturation analysis revealed high levels of receptors (mean +/- s.d. = 2.5 +/- 1 x 10(5) surface receptors per cell) which were of high affinity (Kd +/- s.d. = 1.0 +/- 0.5 nmol l-1). Although DU145 cells express high levels of EGF receptors, DNA synthesis was only minimally affected by exogenous EGF and TGF alpha.
Similar articles
-
Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines.Br J Cancer. 1992 Feb;65(2):177-82. doi: 10.1038/bjc.1992.37. Br J Cancer. 1992. PMID: 1739613 Free PMC article.
-
Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines.Br J Cancer. 1994 Jan;69(1):8-15. doi: 10.1038/bjc.1994.2. Br J Cancer. 1994. PMID: 8286215 Free PMC article.
-
Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha.Cancer Res. 1991 Jun 1;51(11):2780-5. Cancer Res. 1991. PMID: 2032218
-
Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway.Br J Cancer. 1994 Nov;70(5):850-6. doi: 10.1038/bjc.1994.410. Br J Cancer. 1994. PMID: 7947089 Free PMC article.
-
Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.Mol Carcinog. 1996 Feb;15(2):134-43. doi: 10.1002/(SICI)1098-2744(199602)15:2<134::AID-MC6>3.0.CO;2-J. Mol Carcinog. 1996. PMID: 8599580
Cited by
-
The current status of scientific research and hormonal treatments for carcinoma of the prostate.Br J Cancer. 1991 Sep;64(3):419-21. doi: 10.1038/bjc.1991.324. Br J Cancer. 1991. PMID: 1911179 Free PMC article. Review. No abstract available.
-
Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment.Urol Res. 1995;23(2):119-25. doi: 10.1007/BF00307942. Urol Res. 1995. PMID: 7676534
-
SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression.Mol Imaging Biol. 2008 May-Jun;10(3):167-75. doi: 10.1007/s11307-008-0133-8. Epub 2008 Feb 23. Mol Imaging Biol. 2008. PMID: 18297364
-
Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines.Br J Cancer. 1992 Feb;65(2):177-82. doi: 10.1038/bjc.1992.37. Br J Cancer. 1992. PMID: 1739613 Free PMC article.
-
Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells.Br J Cancer. 1992 Aug;66(2):254-9. doi: 10.1038/bjc.1992.253. Br J Cancer. 1992. PMID: 1503897 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical